TABLE 1.
Surveillance study 1 |
Surveillance study 2 |
Surveillance study 3 |
Total |
|
Year(s) study was performed | 2011–2012 | 2014–2015 | 2015–2016 | – |
No. of feedlots sampleda | ||||
Canada | 10 | 17 | 12 | 31 |
United States | 2 | 0 | 0 | 2 |
No. animals sampled in the study | 68 | 528 | 159 | 755 |
No. of isolates recovered | ||||
M. haemolytica | 55 | 238 | 35 | 408 |
P. multocida | 8 | 85 | 34 | 140 |
Percentage of isolates found to be MDRb (No. of strains screened with AST) | ||||
M. haemolytica | 67.3 (55) | 55 (238) | 81.8 (33) | – |
P. multocida | 50 (8) | 70.5 (85) | 90.9 (33) | – |
No. of MDR isolates included in this analysis | ||||
M. haemolytica | 40 | 80 | 27 | 147 |
P. multocida | 6 | 34 | 30 | 70 |
Total | 46 | 114 | 57 | 217 |
aValues include feedlots where MDR strains were recovered. Only three feedlots were represented in more than one study, both sampled in study 2 and study 3 (Supplementary Table S1).bMDR = an isolate expressing resistance to ≥3 antimicrobial classes.